Interferon: benefit beyond hepatitis therapy?
Mallat
D B
DB
Division of Gastroenterology, Baylor College of Medicine, Houston, Texas, USA.
El-Serag
H B
HB
D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control / Q000601:surgery* / Q000821:virology*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000517:prevention & control / Q000601:surgery* / Q000821:virology*; D008137:Longitudinal Studies; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011182:Postoperative Care; D016032:Randomized Controlled Trials as Topic
D000998:Antiviral Agents; D016898:Interferon-alpha